Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2025 | Breaking down stigmas in endometrial cancer healthcare

Jalid Sehouli, MD, Charité Universitätsmedizin Berlin, Berlin, Germany, discusses breaking down stigmas regarding intervention and care strategies for patients who have or have had endometrial cancer. He urges priming before surgery, including fully informing the patient of their options and potentially changing nutrition and lifestyle as they can be risk factors for development and recurrence. Moreover, women should be empowered to share their experience opens up the healthcare conversation to improve the interaction of different health professionals. This interview took place during the 2025 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

First of all, we have to think how we can prepare patients for surgery, for chemotherapy, for immunotherapy. And I suggest that we use a priming concept. Priming, what does it mean? P for pain management, I for information, M for medical information because very few women know what is the risk of endometrial cancer, what are the treatment strategies. And even to look at the interaction with the other polypharmacists, because many of the women have five, six, seven drugs, but nobody takes care how they interact...

First of all, we have to think how we can prepare patients for surgery, for chemotherapy, for immunotherapy. And I suggest that we use a priming concept. Priming, what does it mean? P for pain management, I for information, M for medical information because very few women know what is the risk of endometrial cancer, what are the treatment strategies. And even to look at the interaction with the other polypharmacists, because many of the women have five, six, seven drugs, but nobody takes care how they interact. And even many of the women are untreated or over-treated. So they need drug clearing. And this is the other eye of the word priming and nutrition lifestyle. So we know that obesity is one of the key elements in developing endometrial cancer. But even it is a risk factor for the recurrence. And we have to add patience to change maybe the lifestyles, not easy, but we know, and the G of the word priming is guidance, psychological support, and to empower the woman to get a second opinion, to ask for clinical trials, and we know that the structure for the advocacy groups is different than we know for breast cancer, but even to decrease the barrier that patients can share their individual experience with other women. This is something what I really support. So this is the prehabilitation aspect of trying to improve the healthcare status of the patient before they go to the individual medical intervention. This is one topic. The second is how we can really change the cancer care program because we know from many surveys and even in our study that this is not really systematically addressed, and we have to talk about these items, lifestyle, we have to talk about genetic, think about Lynch syndrome or other genetic risk disorders, and we have to talk about how we can follow up the patients if they have really a higher risk for heart attacks, so how we can use maybe digital applications to improve the interaction of the different health professionals, and I think this is something what we even have to underline, and we know that with endometrial cancer, many of them are long-term survivors. But what’s about her bone health or the mental health? So long-term survivorship, especially for endometrial cancer patients, I think is crucial. So these are topics what I think we have to change the classical system, and I’m very proud that we see so much dynamic, but we have to empower and yes, to change our classical traditional behavior.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...